These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 21521873)
1. HLA-A2-matched peripheral blood mononuclear cells from type 1 diabetic patients, but not nondiabetic donors, transfer insulitis to NOD-scid/γc(null)/HLA-A2 transgenic mice concurrent with the expansion of islet-specific CD8+ T cells. Whitfield-Larry F; Young EF; Talmage G; Fudge E; Azam A; Patel S; Largay J; Byrd W; Buse J; Calikoglu AS; Shultz LD; Frelinger JA Diabetes; 2011 Jun; 60(6):1726-33. PubMed ID: 21521873 [TBL] [Abstract][Full Text] [Related]
2. Islet-specific CTL cloned from a type 1 diabetes patient cause beta-cell destruction after engraftment into HLA-A2 transgenic NOD/scid/IL2RG null mice. Unger WW; Pearson T; Abreu JR; Laban S; van der Slik AR; der Kracht SM; Kester MG; Serreze DV; Shultz LD; Griffioen M; Drijfhout JW; Greiner DL; Roep BO PLoS One; 2012; 7(11):e49213. PubMed ID: 23155466 [TBL] [Abstract][Full Text] [Related]
3. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Christianson SW; Shultz LD; Leiter EH Diabetes; 1993 Jan; 42(1):44-55. PubMed ID: 8093606 [TBL] [Abstract][Full Text] [Related]
4. Equivalent specificity of peripheral blood and islet-infiltrating CD8+ T lymphocytes in spontaneously diabetic HLA-A2 transgenic NOD mice. Enée E; Martinuzzi E; Blancou P; Bach JM; Mallone R; van Endert P J Immunol; 2008 Apr; 180(8):5430-8. PubMed ID: 18390725 [TBL] [Abstract][Full Text] [Related]
5. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice. Banuelos SJ; Shultz LD; Greiner DL; Burzenski LM; Gott B; Lyons BL; Rossini AA; Appel MC Clin Immunol; 2004 Sep; 112(3):273-83. PubMed ID: 15308121 [TBL] [Abstract][Full Text] [Related]
6. Temporal relationship between immune cell influx and the expression of inducible nitric oxide synthase, interleukin-4 and interferon-gamma in pancreatic islets of NOD mice following adoptive transfer of diabetic spleen cells. Reddy S; Karanam M; Krissansen G; Nitschke K; Neve J; Poole CA; Ross JM Histochem J; 2000 Apr; 32(4):195-206. PubMed ID: 10872884 [TBL] [Abstract][Full Text] [Related]
7. Prevention of "Humanized" diabetogenic CD8 T-cell responses in HLA-transgenic NOD mice by a multipeptide coupled-cell approach. Niens M; Grier AE; Marron M; Kay TW; Greiner DL; Serreze DV Diabetes; 2011 Apr; 60(4):1229-36. PubMed ID: 21346176 [TBL] [Abstract][Full Text] [Related]
8. Generation of β cell-specific human cytotoxic T cells by lentiviral transduction and their survival in immunodeficient human leucocyte antigen-transgenic mice. Babad J; Mukherjee G; Follenzi A; Ali R; Roep BO; Shultz LD; Santamaria P; Yang OO; Goldstein H; Greiner DL; DiLorenzo TP Clin Exp Immunol; 2015 Mar; 179(3):398-413. PubMed ID: 25302633 [TBL] [Abstract][Full Text] [Related]
9. Activation of insulin-reactive CD8 T-cells for development of autoimmune diabetes. Wong FS; Siew LK; Scott G; Thomas IJ; Chapman S; Viret C; Wen L Diabetes; 2009 May; 58(5):1156-64. PubMed ID: 19208910 [TBL] [Abstract][Full Text] [Related]
10. Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells. Grewal IS; Grewal KD; Wong FS; Picarella DE; Janeway CA; Flavell RA J Exp Med; 1996 Nov; 184(5):1963-74. PubMed ID: 8920883 [TBL] [Abstract][Full Text] [Related]
11. The pathogenicity of islet-infiltrating lymphocytes in the non-obese diabetic (NOD) mouse. Ablamunits V; Elias D; Cohen IR Clin Exp Immunol; 1999 Feb; 115(2):260-7. PubMed ID: 9933451 [TBL] [Abstract][Full Text] [Related]
12. The role of CD8+ cells, cell degeneration, and Fas ligand in insulitis after intraperitoneal transfer of NOD splenocytes. Sainio-Pöllänen S; Liukas A; Pöllänen P; Simell O Pancreas; 1999 Apr; 18(3):282-93. PubMed ID: 10206487 [TBL] [Abstract][Full Text] [Related]
13. Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones. Differential requirement for CD8 T-cells. Peterson JD; Haskins K Diabetes; 1996 Mar; 45(3):328-36. PubMed ID: 8593938 [TBL] [Abstract][Full Text] [Related]
14. Islet-infiltrating lymphocytes from prediabetic NOD mice rapidly transfer diabetes to NOD-scid/scid mice. Rohane PW; Shimada A; Kim DT; Edwards CT; Charlton B; Shultz LD; Fathman CG Diabetes; 1995 May; 44(5):550-4. PubMed ID: 7729614 [TBL] [Abstract][Full Text] [Related]
15. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction. Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970 [TBL] [Abstract][Full Text] [Related]
16. Functional evidence for the mediation of diabetogenic T cell responses by HLA-A2.1 MHC class I molecules through transgenic expression in NOD mice. Marron MP; Graser RT; Chapman HD; Serreze DV Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13753-8. PubMed ID: 12361980 [TBL] [Abstract][Full Text] [Related]
17. IFN-γ receptor deficiency prevents diabetes induction by diabetogenic CD4+, but not CD8+, T cells. Yi Z; Li L; Garland A; He Q; Wang H; Katz JD; Tisch R; Wang B Eur J Immunol; 2012 Aug; 42(8):2010-8. PubMed ID: 22865049 [TBL] [Abstract][Full Text] [Related]
18. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice. Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-15 plays an essential role in the pathogenesis of autoimmune diabetes in the NOD mouse. Bobbala D; Chen XL; Leblanc C; Mayhue M; Stankova J; Tanaka T; Chen YG; Ilangumaran S; Ramanathan S Diabetologia; 2012 Nov; 55(11):3010-20. PubMed ID: 22890824 [TBL] [Abstract][Full Text] [Related]
20. The Presence and Preferential Activation of Regulatory T Cells Diminish Adoptive Transfer of Autoimmune Diabetes by Polyclonal Nonobese Diabetic (NOD) T Cell Effectors into NSG versus NOD-scid Mice. Presa M; Chen YG; Grier AE; Leiter EH; Brehm MA; Greiner DL; Shultz LD; Serreze DV J Immunol; 2015 Oct; 195(7):3011-9. PubMed ID: 26283479 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]